Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2012 Jun 1;5(3):553-60.
doi: 10.1161/CIRCEP.111.966739. Epub 2012 Feb 14.

Dietary omega-3 fatty acids and susceptibility to ventricular fibrillation: lack of protection and a proarrhythmic effect

George E Billman  1 , Cynthia A Carnes, Philip B Adamson, Emilio Vanoli, Peter J Schwartz
Affiliations
Comparative Study

Dietary omega-3 fatty acids and susceptibility to ventricular fibrillation: lack of protection and a proarrhythmic effect

George E Billman et al. Circ Arrhythm Electrophysiol. .

Erratum in

  • Circ Arrhythm Electrophysiol. 2012 Aug 1;5(4):e89

Abstract

Background: Recent clinical studies that evaluated the effects of supplemental omega-3 polyunsaturated fatty acids (n-3 PUFAs) on sudden cardiac death have yielded conflicting results. Our aim was to clarify this issue using an established and clinical relevant canine model of sudden cardiac death.

Methods and results: Susceptibility to ventricular fibrillation (VF) was evaluated using a 2-minute left circumflex artery occlusion during the last minute of an exercise test in 76 dogs (from 2 independent studies) with healed myocardial infarctions (MI); 44 developed VF (susceptible, VF+), whereas 32 did not (resistant, VF-). These dogs were then randomly assigned to either placebo (1 g/d, corn oil; 15 VF+, 11 VF-) or n-3 PUFA (1-4 g/d, docosahexaenoic acid+eicosapentaenoic acid ethyl esters, 29 VF+, 21 VF-) groups. Seven sham (no-MI) dogs were also treated with n-3 PUFA (4 g/d). After treatment (3 months), the exercise+ischemia test was repeated. Dietary n-3 PUFAs produced significant (P<0.01) increases in red blood cell and left ventricular n-3 PUFA levels. Nine post-MI (5 placebo versus 4 n-3 PUFA) and 2 sham dogs died suddenly during the 3-month treatment period. The n-3 PUFA treatment failed to prevent arrhythmias in VF+ dogs (decreased in 27% placebo versus 24% n-3 PUFA, P=0.5646) but induced VT/VF in VF- animals (n-3 PUFA 33% versus placebo 0%, P=0.0442).

Conclusions: Despite large increases in cardiac tissue n-3 PUFA content, dietary n-3 PUFAs did not prevent ischemia-induced VF and actually increased arrhythmia susceptibility in both noninfarcted and low-risk post-MI dogs.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: W.S.H. is a scientific advisor to Omthera, Aker Biomarine, and Amarin, is a speaker for GlaxoSmithKline, and is the owner of OmegaQuant Analytics, a company offering blood omega-3 testing.

Figures

Figure 1
Figure 1
A flow chart of the post-MI animals used in Study 2. The exercise + ischemia test could not be repeated at the end of treatment in some animals due to occluder failure [11 VF+ (5 placebo, 6 n-3 PUFA) and 5 VF− (2 placebo, 3 n-3 PUFA)] or spontaneous death (VF+: 5 placebo, 4 n-3 PUFA). VF = ventricular fibrillation; n-3 PUFA = omega-3 polyunsaturated fatty acids.
Figure 2
Figure 2
The response of each susceptible (VF+) dog before and at the end of a 3 month treatment period with either placebo (Fig 2a., 1 g/day corn oil, n=15) or n-3 PUFA (Fig 2b., 1-4 g/day, n=21). Only the results of the post-MI animals used in the Study 2 are shown. Note that 9 dogs died spontaneously (SD; 5 placebo, 4 n-3 PUFA) and could not receive a post-treatment exercise + ischemia test. The n-3 PUFA treatment did not prevent ventricular tachyarrhythmias for any n-3 PUFA dose (1 g/day P=0.7278; 2 g/day, P=0.4769; 4 g/day P=0.5159). VF = ventricular fibrillation; PVCs = premature ventricular complexes; Pre = before the onset of treatment; Post = after 3-months of treatment. Open circle = 1 g/day; open square = 2 g/day, and closed circle = 4 g/day.
Figure 2
Figure 2
The response of each susceptible (VF+) dog before and at the end of a 3 month treatment period with either placebo (Fig 2a., 1 g/day corn oil, n=15) or n-3 PUFA (Fig 2b., 1-4 g/day, n=21). Only the results of the post-MI animals used in the Study 2 are shown. Note that 9 dogs died spontaneously (SD; 5 placebo, 4 n-3 PUFA) and could not receive a post-treatment exercise + ischemia test. The n-3 PUFA treatment did not prevent ventricular tachyarrhythmias for any n-3 PUFA dose (1 g/day P=0.7278; 2 g/day, P=0.4769; 4 g/day P=0.5159). VF = ventricular fibrillation; PVCs = premature ventricular complexes; Pre = before the onset of treatment; Post = after 3-months of treatment. Open circle = 1 g/day; open square = 2 g/day, and closed circle = 4 g/day.
Figure 3
Figure 3
The response of each resistant (VF−) dog before and at the end of a 3 month treatment period with either placebo (Fig 3a., 1 g/day corn oil, n=10) or n-3 PUFA (Fig 3b., 1–4 g/day, n=21). Only the results of the post-MI animals used in the Study 2 are shown. Note that the n-3 PUFA treatment increased (P=0.442) the severity of arrhythmias in one third (7 of 21; 3 of 5 with 2 g/day & 4 of 15 with 4 g/day) of these dogs while the placebo treatment did not induce arrhythmias in any animal. * indicates an episode of ventricular fibrillation (VF). VT = ventricular tachycardia; PVCs = premature ventricular complexes; none = no arrhythmias; Pre = before the onset of treatment; Post = after 3-months of treatment. Open circle = 1 g/day; open square = 2 g/day, and closed circle = 4 g/day.
Figure 3
Figure 3
The response of each resistant (VF−) dog before and at the end of a 3 month treatment period with either placebo (Fig 3a., 1 g/day corn oil, n=10) or n-3 PUFA (Fig 3b., 1–4 g/day, n=21). Only the results of the post-MI animals used in the Study 2 are shown. Note that the n-3 PUFA treatment increased (P=0.442) the severity of arrhythmias in one third (7 of 21; 3 of 5 with 2 g/day & 4 of 15 with 4 g/day) of these dogs while the placebo treatment did not induce arrhythmias in any animal. * indicates an episode of ventricular fibrillation (VF). VT = ventricular tachycardia; PVCs = premature ventricular complexes; none = no arrhythmias; Pre = before the onset of treatment; Post = after 3-months of treatment. Open circle = 1 g/day; open square = 2 g/day, and closed circle = 4 g/day.
See this image and copyright information in PMC

Comment in

References

    1. Dyerberg J, Bang HO, Stoffersen E, Moncada S, Vane JR. Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis? Lancet. 1978;2:117–119. - PubMed
    1. Kromhout D, Bosschieter EB, de Lezenne CC. The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med. 1985;312:1205–1209. - PubMed
    1. Burr ML, Gilbert JF, Holliday RM, Elwood PC, Fehily AM, Rogers S, Sweetnam PM, Deadman NM. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART) Lancet. 1989;2:757–761. - PubMed
    1. Nilsen DWT, Albrektsen G, Landmark K, Moen S, Aarsland T, Woie Effects of a high-dose concentrate on n-3 fatty acids or corn oil introduced early after acute myocardial infarction on serum triacylglyerol and HDL cholesterol. Am J Clin Nutr. 2001;74:50–56. - PubMed
    1. Marchioli R, Barzi F, Bomba E, Chieffo C, Di Gregorio D, Di Mascio R, Franzosi MG, Geraci E, Levantesi G, Maggioni AP, Mantini L, Marfisi RM, Mastrogiuseppi G, Mininni N, Nicolisi GL, Santini M, Schweiger C, Tavazzi L, Tognoni G, Tucci C, Valagussa F. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation. 2002;105:1897–1903. - PubMed

Publication types

Substances